Literature DB >> 19396148

Testicular mixed germ cell tumors: a morphological and immunohistochemical study using stem cell markers, OCT3/4, SOX2 and GDF3, with emphasis on morphologically difficult-to-classify areas.

Anuradha Gopalan1, Deepti Dhall, Semra Olgac, Samson W Fine, James E Korkola, Jane Houldsworth, Raju S Chaganti, George J Bosl, Victor E Reuter, Satish K Tickoo.   

Abstract

Stem cell markers, OCT3/4, and more recently SOX2 and growth differentiation factor 3 (GDF3), have been reported to be expressed variably in germ cell tumors. We investigated the immunohistochemical expression of these markers in different testicular germ cell tumors, and their utility in the differential diagnosis of morphologically difficult-to-classify components of these tumors. A total of 50 mixed testicular germ cell tumors, 43 also containing difficult-to-classify areas, were studied. In these areas, multiple morphological parameters were noted, and high-grade nuclear details similar to typical embryonal carcinoma were considered 'embryonal carcinoma-like high-grade'. Immunohistochemical staining for OCT3/4, c-kit, CD30, SOX2, and GDF3 was performed and graded in each component as 0, negative; 1+, 1-25%; 2+, 26-50%; and 3+, >50% positive staining cells. The different components identified in these tumors were seminoma (8), embryonal carcinoma (50), yolk sac tumor (40), teratoma (40), choriocarcinoma (3) and intra-tubular germ cell neoplasia, unclassified (35). By immunohistochemistry, the staining patterns were OCT3/4 -3+, all seminomas, embryonal carcinomas and intra-tubular germ cell neoplasia; SOX2 -3+, all embryonal carcinomas and -2 to 3+, 11/14 (79%) primitive neuroectodermal components in immature teratomas; GDF3 -2 to 3+, all yolk sac tumors, seminomas and intra-tubular germ cell neoplasia and 1 to 2+, 40/50 embryonal carcinomas. A total of 34/43 (79%) of difficult-to-classify areas stained 3+ for OCT3/4, CD30, and SOX2, similar to embryonal carcinoma. Among these areas, only 'embryonal carcinoma-like high-grade' nuclear details were significantly associated with such an immunophenotype. Thus, SOX2 is expressed in embryonal carcinoma and primitive neuroectoderm of teratoma, and unlike OCT3/4, not in intra-tubular germ cell neoplasia and seminoma. Therefore, it may be useful in the distinction of seminoma from embryonal carcinoma, and potentially in diagnosing early carcinomatous differentiation in seminoma. GDF3 positivity, in the absence of OCT3/4 and CD30, combined with morphological features, is helpful in the diagnosis of yolk sac tumor. 'Embryonal carcinoma-like high-grade' nuclear details are the most important morphological criterion for the diagnosis of embryonal carcinoma in difficult-to-classify areas.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19396148     DOI: 10.1038/modpathol.2009.66

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  17 in total

Review 1.  Cervical lymph node metastases from remote primary tumor sites.

Authors:  Fernando López; Juan P Rodrigo; Carl E Silver; Missak Haigentz; Justin A Bishop; Primož Strojan; Dana M Hartl; Patrick J Bradley; William M Mendenhall; Carlos Suárez; Robert P Takes; Marc Hamoir; K Thomas Robbins; Ashok R Shaha; Jochen A Werner; Alessandra Rinaldo; Alfio Ferlito
Journal:  Head Neck       Date:  2015-12-29       Impact factor: 3.147

2.  Fatty acid synthase overexpression in adult testicular germ cell tumors: potential role in the progression of non-seminomatous germ cell tumors.

Authors:  Kosuke Miyai; Keiichi Iwaya; Tomohiko Asano; Seiichi Tamai; Osamu Matsubara; Hitoshi Tsuda
Journal:  Virchows Arch       Date:  2013-12-14       Impact factor: 4.064

Review 3.  Testicular cancer: biology and biomarkers.

Authors:  Leendert H J Looijenga; Hans Stoop; Katharina Biermann
Journal:  Virchows Arch       Date:  2014-02-01       Impact factor: 4.064

4.  Absent Testis With a Mediastinal Germ Cell Tumor.

Authors:  Shreyas Bellur; Sreekar Balasundaram; Ashitha Nanaiah
Journal:  Cureus       Date:  2022-04-25

5.  Cripto: Expression, epigenetic regulation and potential diagnostic use in testicular germ cell tumors.

Authors:  Cassy M Spiller; Ad J M Gillis; Guillaume Burnet; Hans Stoop; Peter Koopman; Josephine Bowles; Leendert H J Looijenga
Journal:  Mol Oncol       Date:  2015-11-18       Impact factor: 6.603

6.  An embryo-specific expressing TGF-β family protein, growth-differentiation factor 3 (GDF3), augments progression of B16 melanoma.

Authors:  Nobuyuki Ehira; Hiroyuki Oshiumi; Misako Matsumoto; Takeshi Kondo; Masahiro Asaka; Tsukasa Seya
Journal:  J Exp Clin Cancer Res       Date:  2010-10-15

Review 7.  Brentuximab vedotin for treatment of non-Hodgkin lymphomas: A systematic review.

Authors:  Garrett K Berger; Ali McBride; Stephanie Lawson; Kelsey Royball; Seongseok Yun; Kevin Gee; Irbaz Bin Riaz; Ahlam A Saleh; Soham Puvvada; Faiz Anwer
Journal:  Crit Rev Oncol Hematol       Date:  2016-11-21       Impact factor: 6.312

8.  Phase II trial of brentuximab vedotin in relapsed/refractory germ cell tumors.

Authors:  Ryan Ashkar; Darren R Feldman; Nabil Adra; Mohammad Abu Zaid; Samuel A Funt; Sandra K Althouse; Susan M Perkins; Christin I Snow; Kayla M Lazzara; Lina M Sego; David I Quinn; Nasser H Hanna; Lawrence H Einhorn; Costantine Albany
Journal:  Invest New Drugs       Date:  2021-05-24       Impact factor: 3.651

9.  Canine testicular tumors: two types of seminomas can be differentiated by immunohistochemistry.

Authors:  Marko Hohšteter; Branka Artuković; Krešimir Severin; Andrea Gudan Kurilj; Ana Beck; Ivan-Conrado Šoštarić-Zuckermann; Željko Grabarević
Journal:  BMC Vet Res       Date:  2014-08-06       Impact factor: 2.741

10.  HMGA2 expression distinguishes between different types of postpubertal testicular germ cell tumour.

Authors:  Lars Kloth; Andrea Gottlieb; Burkhard Helmke; Werner Wosniok; Thomas Löning; Käte Burchardt; Gazanfer Belge; Kathrin Günther; Jörn Bullerdiek
Journal:  J Pathol Clin Res       Date:  2015-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.